Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110824

Reduced Platelet Thromboxane Formation in Uremia. EVIDENCE FOR A FUNCTIONAL CYCLOOXYGENASE DEFECT

G. Remuzzi,1 A. Benigni,1 P. Dodesini,1 A. Schieppati,1 M. Livio,1 G. De Gaetano,1 J. S. Day,2 W. L. Smith,2 E. Pinca,3 P. Patrignani,3 and C. Patrono3

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Remuzzi, G. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Benigni, A. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Dodesini, P. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Schieppati, A. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Livio, M. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by De Gaetano, G. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Day, J. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Smith, W. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Pinca, E. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Patrignani, P. in: PubMed | Google Scholar

1Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Istituto di Ricerche Farmacologiche “Mario Negri”, 20157 Milano, Italy

2Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824

Department of Pharmacology, Catholic University School of Medicine, 00168 Rome, Italy

Find articles by Patrono, C. in: PubMed | Google Scholar

Published March 1, 1983 - More info

Published in Volume 71, Issue 3 on March 1, 1983
J Clin Invest. 1983;71(3):762–768. https://doi.org/10.1172/JCI110824.
© 1983 The American Society for Clinical Investigation
Published March 1, 1983 - Version history
View PDF
Abstract

A qualitative platelet abnormality and a bleeding tendency are frequently associated with renal failure and uremia. We demonstrated previously that uremic patients display an abnormal platelet aggregation to arachidonic acid and reduced malondialdehyde production in response to thrombin and arachidonic acid. The objectives of this investigation were: (a) to compare platelet prostaglandin (PG) and thromboxane (TX) production in whole blood and in platelet-rich plasma (PRP) of 21 uremic patients and 22 healthy subjects; (b) to evaluate the concentration and activity of platelet PG- and TX-forming enzymes; (c) to assess the functional responsiveness of the platelet TXA2/PGH2 receptor; (d) to explore the hemostatic consequences of partially reduced TXA2 production.

Platelet immunoreactive TXB2 production during whole blood clotting was significantly reduced, by ∼60%, in uremic patients as compared to age- and sex-matched controls. Exogenous thrombin (5-30 IU/ml) failed to restore normal TXB2 production in uremic platelets. Uremic PRP produced comparable or slightly higher amounts of TXB2 than normal PRP at arachidonate concentrations 0.25-1 mM. However, when exposed to substrate concentrations >2 mM, uremic PRP produced significantly less TXB2 than normal PRP. To discriminate between reduced arachidonic acid oxygenation and altered endoperoxide metabolism, the time course of immunoreactive TXB2 and PGE2 production was measured during whole blood clotting. The synthesis and release of both cyclooxygenase-derived products was slower and significantly reduced, at all time intervals considered. Furthermore, PGI2 production in whole blood, as reflected by serum immunoreactive 6-keto-PGF1α concentrations, was significantly reduced in uremic patients as compared with healthy subjects. PGH synthase levels, as determined by an immunoradiometric assay, were not significantly different in platelets from uremic patients as compared to control platelets. A single 40-mg dose of aspirin given to five healthy volunteers reduced their serum TXB2 to levels found in uremic patients. This was associated with a significant increase of threshold aggregating concentrations of ADP and arachidonic acid and prolongation of bleeding time. Substantially similar threshold concentrations of U46619, a TXA2 agonist, induced aggregation of normal and uremic platelets. Prostacyclin induced a significant elevation of uremic platelet cyclic AMP, which was suppressed by U46619, further suggesting normal responsiveness of the TXA2/PGH2 receptor.

We conclude that: (a) an abnormality of platelet arachidonic acid metabolism exists in uremia, leading to a reduced TXA2 production; (b) the characteristics of this abnormality are consistent with a functional cyclooxygenase defect; (c) reduced TXA2 production may partially explain the previously described abnormality of platelet function in uremia.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 762
page 762
icon of scanned page 763
page 763
icon of scanned page 764
page 764
icon of scanned page 765
page 765
icon of scanned page 766
page 766
icon of scanned page 767
page 767
icon of scanned page 768
page 768
Version history
  • Version 1 (March 1, 1983): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts